Is nocturnal enuresis a predisposing factor for the overactive bladder?
Nocturnal enuresis
overactive bladder
predisposing cause
Journal
Turkish journal of medical sciences
ISSN: 1303-6165
Titre abrégé: Turk J Med Sci
Pays: Turkey
ID NLM: 9441758
Informations de publication
Date de publication:
18 06 2019
18 06 2019
Historique:
entrez:
18
6
2019
pubmed:
18
6
2019
medline:
19
2
2020
Statut:
epublish
Résumé
This study aimed to perform a limited observational study to ascertain whether there is statistical support that nocturnal enuresis (NE) is a predisposing factor in the development of overactive bladder (OAB). The authors recruited patients diagnosed with OAB over a period of twelve months, and those who declared a history of NE were asked additional questions regarding the features of their NE. A total of 285 patients were diagnosed with overactive bladder, and 98 (34.38%) of them had previously displayed NE symptoms that had diminished before reaching the median age of 9.83. Separation of patients by sex revealed a male majority (58.16%). Additionally, most patients had urban origins (75.51%). The median time span from remission of NE to diagnosis of OAB was 24.79 years, and the median age at which patients began to suffer was 31.80 years. Behavioral factors (smoking, alcohol consumption) and psychological and infectious factors (past history of urinary tract infection) were identified at varying degrees. The presence of NE in a third of the patients who developed over time OAB and the earlier onset of OAB for these patients suggests a causal physiopathological relationship between NE and OAB. The preponderance of urban patients confirms the existence of acquired urban triggering factors of OAB (nutritious, social, or professional).
Sections du résumé
Background/aim
This study aimed to perform a limited observational study to ascertain whether there is statistical support that nocturnal enuresis (NE) is a predisposing factor in the development of overactive bladder (OAB).
Materials and methods
The authors recruited patients diagnosed with OAB over a period of twelve months, and those who declared a history of NE were asked additional questions regarding the features of their NE.
Results
A total of 285 patients were diagnosed with overactive bladder, and 98 (34.38%) of them had previously displayed NE symptoms that had diminished before reaching the median age of 9.83. Separation of patients by sex revealed a male majority (58.16%). Additionally, most patients had urban origins (75.51%). The median time span from remission of NE to diagnosis of OAB was 24.79 years, and the median age at which patients began to suffer was 31.80 years. Behavioral factors (smoking, alcohol consumption) and psychological and infectious factors (past history of urinary tract infection) were identified at varying degrees.
Conclusion
The presence of NE in a third of the patients who developed over time OAB and the earlier onset of OAB for these patients suggests a causal physiopathological relationship between NE and OAB. The preponderance of urban patients confirms the existence of acquired urban triggering factors of OAB (nutritious, social, or professional).
Identifiants
pubmed: 31203588
doi: 10.3906/sag-1604-116
pmc: PMC7018347
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
703-709Références
Pediatr Rev. 2001 Dec;22(12):399-407
pubmed: 11731679
BJU Int. 2008 Jun;101(11):1388-95
pubmed: 18454794
Eur J Obstet Gynecol Reprod Biol. 2012 Sep;164(1):105-9
pubmed: 22762841
Neurourol Urodyn. 2012 Jun;31(5):634-6
pubmed: 22461203
J Comp Neurol. 1986 Aug 22;250(4):449-61
pubmed: 3760249
J Urol. 2012 Dec;188(6 Suppl):2455-63
pubmed: 23098785
Exp Brain Res. 1984;55(1):145-51
pubmed: 6745345
J Urol. 2014 Jun;191(6):1866-70
pubmed: 24423434
BJU Int. 2003 Jul;92(1):69-77
pubmed: 12823386
Pediatr Nephrol. 1995 Jun;9(3):94-103
pubmed: 7632548
Rev Urol. 2002;4 Suppl 4:S7-S18
pubmed: 16986023
World J Urol. 2003 May;20(6):327-36
pubmed: 12811491
J Urol. 2006 Jul;176(1):314-24
pubmed: 16753432
South Med J. 2002 Feb;95(2):183-7
pubmed: 11846242
Urology. 1997 Dec;50(6A Suppl):36-52; discussion 53-6
pubmed: 9426749
Public Health Nutr. 2004 Oct;7(7):885-91
pubmed: 15482614
Open Access J Urol. 2010 Feb 11;2:11-24
pubmed: 24198609
N Engl J Med. 2004 Feb 19;350(8):786-99
pubmed: 14973214
BJU Int. 2005 May;95(7):1058-62
pubmed: 15839932
Eur Urol. 2006 Dec;50(6):1306-14; discussion 1314-5
pubmed: 17049716
Korean J Urol. 2012 Aug;53(8):541-6
pubmed: 22949998
Urology. 2012 Jul;80(1):90-6
pubmed: 22748867
Urology. 1997 Dec;50(6A Suppl):57-67; discussion 68-73
pubmed: 9426752
Neurourol Urodyn. 2011 Nov;30(8):1448-55
pubmed: 21826714
Neurourol Urodyn. 2002;21(2):167-78
pubmed: 11857671
Pediatr Nephrol. 2011 Aug;26(8):1207-14
pubmed: 21267599
Eur Urol. 1998;33 Suppl 3:12-5
pubmed: 9599730
Br J Urol. 1996 Oct;78(4):602-6
pubmed: 8944518
Lancet. 2001 Aug 4;358(9279):401-3
pubmed: 11502339